CJC-1295 without DAC 5mg + IPA 5mg

Researchers investigate short-acting peptide interaction using the CJC-1295 ipamorelin blend in controlled settings. Short-acting peptides exhibit briefer activity periods compared to modified extended-release versions. Laboratory teams explore peptide stability and structure analysis under various experimental conditions. Scientists study controlled laboratory peptide models examining molecular behaviors. Research groups examine how multiple peptides interact within the same system. These studies occur exclusively in research environments without clinical applications.

The CJC-1295 ipamorelin blend is investigated in research settings for dual-peptide interaction studies. Scientists have studied this combination within controlled laboratory environments using standardized protocols. The formulation is explored for experimental peptide interaction research in academic facilities. Researchers evaluate the blend under controlled conditions without therapeutic claims.

Store the CJC-1295 ipamorelin blend in cool, dry, light-protected conditions. Recommended storage temperature ranges between 2-8°C for unopened vials. This product is intended for laboratory handling only by qualified research personnel. Qualified personnel possess training in peptide reconstitution and proper handling methods. Avoid moisture exposure as humidity can compromise peptide stability and quality. Moisture refers to water vapor in air or direct liquid water contact. Avoid heat exposure above specified temperature ranges to preserve peptide integrity. Reconstituted solutions should follow established laboratory guidelines for peptide research protocols.

Each CJC-1295 ipamorelin blend batch undergoes comprehensive purity verification procedures. Purity verification confirms both peptides meet quality specifications within the blend. Our processes ensure batch-to-batch consistency across all research supply orders. Internal quality assurance standards follow research-grade supply positioning for peptide formulations. Research-grade positioning means products meet specifications required for scientific laboratory use. Testing protocols verify both peptides maintain structural integrity and purity levels. Every unit receives quality approval before distribution authorization. Documentation packages accompany each order for institutional tracking and compliance purposes.

• CAS: CJC-1295: 863288-34-0 Ipamorelin: 170851-70-4
• Chemical Formula: CJC-1295 No DAC: C₁₅₂H₂₅₂N₄₄O₄₂ Ipamorelin: C₃₈H₄₉N₉O₅
• Molecular Weight: CJC-1295 No DAC: ~3367.9 g/mol Ipamorelin: ~711.9 g/mol
• Peptide Sequence: Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 MOD-GRF(1-29) CJC-1295 No DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg
• Synonyms: Ipamorelin Acetate, IPAM, NNC-26-0161 MOD-GRF(1-29), CJC-1295 without DAC, modgrf
• Shelf life: 24 months from the manufacturing date.

CJC-1295 No DAC is a synthetic peptide designed for short-duration research studies. This compound lacks the Drug Affinity Complex modification found in extended versions. Drug Affinity Complex is a chemical addition that prolongs peptide activity duration. Without this modification, researchers can study rapid peptide behaviors in experimental systems. Scientists investigate how unmodified peptides function in controlled laboratory environments.

Ipamorelin is a research peptide explored in controlled laboratory environments. This synthetic compound consists of a specific amino acid sequence studied for molecular properties. Researchers examine how this peptide behaves in various experimental frameworks. Laboratory studies investigate peptide stability and structural characteristics under controlled conditions.

This dual-peptide formulation combines CJC-1295 No DAC and ipamorelin for research flexibility. Research flexibility means the blend supports various experimental protocol designs. Each component undergoes high-purity testing and batch verification for quality standards. Batch verification ensures each production run maintains consistent quality specifications. The blend is designed for controlled laboratory environments conducting peptide interaction research. Secure packaging with discreet shipment protects peptide integrity during transit to research facilities.